<DOC>
	<DOCNO>NCT00346333</DOCNO>
	<brief_summary>The purpose trial determine whether lutein addition vitamin A slow course retinitis pigmentosa .</brief_summary>
	<brief_title>Clinical Trial Lutein Patients With Retinitis Pigmentosa Receiving Vitamin A</brief_title>
	<detailed_description>Retinitis pigmentosa ( RP ) group inherit retinal degeneration worldwide prevalence approximately 1 4,000 . Patients typically report night blindness difficulty mid-peripheral visual field adolescence . As condition progress , lose far peripheral visual field . Most patient reduction central vision 60 year leave untreated . Vitamin A palmitate , 15,000 International Units ( IU ) /d omega-3 rich diet show slow progression condition among adults typical form . ( see Archives Ophthalmology,111:761-772,1993 ; Archives Ophthalmology 122 : 1306-1314 , 2004 ; Archives Ophthalmology 130 ( 6 ) :701-711,2013 ) . The present study randomize , control , double-masked trial plan duration 5 years.Two hundred forty adult typical form RP assign either lutein 12mg/d control group . Patients group receive 15,000 IU/day vitamin A palmitate addition supplement study . Participants agree know content supplement group assignment end trial . The main outcome measurement total point score 30-2 program Humphrey Field analyzer ( HFA ) . In addition , total point score 60-4 program , total point score 30-2 60-4 program combine , computer-averaged 30-Hz cone Electroretinogram ( ERG ) amplitude Early Treatment Diabetic Retinopathy Study ( ETDRS ) visual acuity measure annually secondary endpoint .</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>Ocular Criteria RP , typical form ( i.e . elevate final dark adaptation threshold , retinal arteriolar narrowing , reduce delayed fullfield ERGs ) . Bestcorrected visual acuity 20/100 good HFA program 302 total point score &gt; = 250 decibel ( dB ) size V white test light No confound ocular disease glaucoma , uveitis , diabetic retinopathy , posterior subcapsular cataract 11 % total lens area ( ie equivalent P3 Lens Opacity Classification System III ) pupil diameter dilation le 6 mm . Dietary Criteria Fruit vegetable intake &lt; 10 servings/d Spinach kale intake &lt; 1 serving/d , i.e . &lt; 1/2 cup cook spinach kale per day Dietary lutein intake &lt; =5.4 mg/d estimate food frequency questionnaire No intake cod liver oil omega3 capsule Dietary preform vitamin A intake &lt; = 10,000 IU/d Supplement intake &lt; = 5,000 IU/d Vitamin A &lt; = 30 IU/d Vitamin E Consumption &lt; = 3 alcoholic beverages/d Medical criterion Age 1860 Body mass index &lt; 40 weight &gt; = 5th percentile age , gender , height Serum retinol level &lt; = 100 micrograms/deciliter serum retinyl ester level &lt; = 380 nanomoles/Liter Serum cholesterol &lt; 300 micrograms/deciliter serum triglyceride level &lt; 400 micrograms/deciliter No clinically significant abnormality blood cell count , glucose level , blood urea nitrogen level , serum lipid panel result serum liver function profile . Not pregnant plan become pregnant Not smoke currently Agreed know tablet content course condition end trial . No disease might affect absorption metabolism lutein vitamin A . Only one patient per family accept study . Women pregnant planning become pregnant ( Vitamin A supplement increase risk birth defect . ) Current participation another clinical trial RP Patients atypical form paravenous RP , pericentral RP , sector RP , unilateral RP , Refsum disease , BardetBiedl syndrome , retinitis punctata albescens conerod dystrophy exclude patient RP profound congenital deafness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Retinitis Pigmentosa , Inherited Retinal Degeneration</keyword>
</DOC>